US BANCORP \DE\ - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 124 filers reported holding CARDLYTICS INC in Q4 2022. The put-call ratio across all filers is 1.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$1,452
-51.6%
88
-72.8%
0.00%
Q3 2022$3,000
-66.7%
323
-19.0%
0.00%
Q2 2022$9,000
+350.0%
399
+1008.3%
0.00%
Q1 2022$2,000
-50.0%
36
-42.9%
0.00%
Q4 2021$4,000
-82.6%
63
-77.0%
0.00%
Q3 2021$23,000
-25.8%
274
+13.2%
0.00%
Q2 2021$31,000
+287.5%
242
+245.7%
0.00%
Q1 2021$8,000
-38.5%
70
-21.3%
0.00%
Q4 2020$13,000
+116.7%
89
+6.0%
0.00%
Q3 2020$6,000
+500.0%
84
+460.0%
0.00%
Q2 2020$1,000150.00%
Other shareholders
CARDLYTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Antipodean Advisors LLC 638,800$35,121,00025.43%
CAS Investment Partners, LLC 5,416,116$297,778,00019.93%
KPS Global Asset Management UK Ltd 1,218,830$67,011,00016.64%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 546,131$30,026,00012.62%
PB INVESTMENT PARTNERS, L.P. 234,175$12,874,0008.75%
Oakcliff Capital Partners, LP 304,736$16,754,0008.69%
Alua Capital Management LP 1,338,359$73,583,0005.03%
683 Capital Management, LLC 1,569,000$86,264,0004.62%
BERYLSON CAPITAL PARTNERS, LLC 62,700$3,447,0004.04%
JS Capital Management LLC 807,000$44,369,0003.45%
View complete list of CARDLYTICS INC shareholders